Here is what the page “RFK Jr-Backed Hepatitis B Vaccine Withholding Trial Approved in Guinea-Bissau” contains. The Guardian Health Oct 9, 2026 • 9:36 PM 1 views A controversial Danish-led trial that will withhold hepatitis B vaccines from thousands of newborns in Guinea-Bissau has received approval to proceed. The study, which aligns with the vaccine agenda of Robert F. Kennedy Jr., the US Secretary of Health and Human Services, will compare health outcomes between infants who receive the recommended hepatitis B vaccine at birth and those who do not.
Researchers argue the trial could clarify whether the birth dose has unintended effects on overall mortality, a claim long promoted by vaccine skeptics. Critics, however, warn that depriving infants of a proven, life-saving vaccine raises serious ethical concerns. Guinea-Bissau, a West African nation with limited healthcare infrastructure, is a frequent site for such studies due to its high infant mortality and low vaccination rates. This listing links straight to the original page, where the content is available in full.